The use of protein phosphatase 2A activators in combination therapies for pancreas cancer

Oncotarget. 2019 Mar 12;10(21):2008-2009. doi: 10.18632/oncotarget.26772.

Authors

Brittany L Allen-Petersen¹, Rosalie C Sears¹

Affiliation

¹ Rosalie C. Sears: Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.

No abstract available

Keywords: MYC; PP2A; pancreatic cancer.

Publication types

Editorial